Trials / Terminated
TerminatedNCT01312454
Safety and Intraocular Pressure (IOP) Lowering Effect of AL-59412C
A Proof of Concept Study to Assess the Safety and IOP-Lowering Effect of AL-59412C Injected Intravitreally
- Status
- Terminated
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 4 (actual)
- Sponsor
- Alcon Research · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study was to assess the safety and efficacy of AL-59412C injected intravitreally relative to Vehicle.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | AL-59412C injectable solution | Concentration 1 and Concentration 2 |
| DRUG | Travoprost injectable solution | |
| DRUG | AL-59412C Vehicle | Inactive ingredients used as placebo |
Timeline
- Start date
- 2011-06-01
- Primary completion
- 2012-01-01
- Completion
- 2012-01-01
- First posted
- 2011-03-10
- Last updated
- 2013-10-25
Source: ClinicalTrials.gov record NCT01312454. Inclusion in this directory is not an endorsement.